Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Canadian Randomized Controlled Trial of DMARD Withdrawal in RA Patients Achieving Therapeutic Response With Cimzia + DMARD Combination Treatment.

NCT01489384 is registered in ClinicalTrials.gov with Pope Research Corporation as lead sponsor.

NCT NCT01489384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01489384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Canadian Randomized Controlled Trial of DMARD Withdrawal in RA Patients Achieving Therapeutic Response With Cimzia + DMARD Combination Treatment.
Lead sponsor
Pope Research Corporation
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2011
Completion date
September 30, 2018
Enrollment
125 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis